NEUROBIOLOGY OF RELAPSE INDUCED BY STRESS AND DRUGS

Information

  • Research Project
  • 6478258
  • ApplicationId
    6478258
  • Core Project Number
    R01DA009750
  • Full Project Number
    3R01DA009750-06S1
  • Serial Number
    9750
  • FOA Number
  • Sub Project Id
  • Project Start Date
    8/5/1995 - 29 years ago
  • Project End Date
    6/30/2002 - 22 years ago
  • Program Officer Name
    PILOTTE, NANCY S
  • Budget Start Date
    7/1/2000 - 24 years ago
  • Budget End Date
    6/30/2002 - 22 years ago
  • Fiscal Year
    2001
  • Support Year
    6
  • Suffix
    S1
  • Award Notice Date
    7/23/2001 - 23 years ago
Organizations

NEUROBIOLOGY OF RELAPSE INDUCED BY STRESS AND DRUGS

DESCRIPTION: (Applicant's Abstract) High rates of relapse to drug use characterize the behavior of experienced heroin and cocaine users. In the proposed research, we will use an animal model to study the neurochemical basis of relapse to drug taking induced by stress. Stress has long been thought to play an important role in relapse in humans, and we have now shown in a series of experiments that it is a powerful inducer of relapse to drug taking in rats after prolonged drug-free periods. We have found that the constellation of neurochemical events involved in relapse induced by stress is distinct from that induced by drugs and that corticotropin-releasing factor and noradrenaline contribute significantly to stress-induced relapse. On the basis of these findings, we now propose to further characterize neurochemical events involved in relapse to cocaine and heroin induced by stressors. Using a reinstatement model in which events that induce relapse to drug seeking can be studied after prolonged drug-free periods in experienced drug users, we aim to identify further the neurotransmitters and brain sites involved in the effect of stress on relapse. Using microdialysis, we will assess the neuronal adaptations that may account for susceptibility to stress-induced relapse that is present after chronic exposure to drugs. Further characterization of the relapse processes in our preclinical model may lead to a better understanding of relapse to drug taking and to the development of medications to prevent relapse in humans.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    3
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    91608
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    279
  • Ed Inst. Type
  • Funding ICs
    NIDA:91608\
  • Funding Mechanism
  • Study Section
    NIDA
  • Study Section Name
    Neuropharmacology Research Subcommittee
  • Organization Name
    CONCORDIA UNIVERSITY
  • Organization Department
  • Organization DUNS
  • Organization City
    MONTREAL
  • Organization State
    PQ
  • Organization Country
    CANADA
  • Organization Zip Code
    H3G1M8
  • Organization District
    CANADA